← Back to Search

MRI and MRS Brain Scans for Brain Mapping in Healthy Subjects

N/A
Recruiting
Led By Steve Li, Ph.D.
Research Sponsored by National Institute of Mental Health (NIMH)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-65 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prospective and ongoing
Awards & highlights

Study Summary

This trial is looking for healthy individuals to participate in a study involving magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) scans of the brain to help researchers develop new techniques for evaluating brain activity and chemistry.

Who is the study for?
This trial is for healthy individuals aged 18 to 65 who can consent and lie flat for about two and a half hours. It's not suitable for those with significant lab abnormalities, pregnant or breastfeeding women, people with metallic implants affected by MRI, claustrophobia, HIV positive individuals, substance use disorders, current psychiatric diagnoses or neurological conditions.Check my eligibility
What is being tested?
The study aims to improve brain imaging techniques using magnetic resonance imaging (MRI) and spectroscopy (MRS). Participants will undergo medical exams followed by an MRI scan of the brain and MRS scans to view and measure brain chemicals.See study design
What are the potential side effects?
Since this trial involves standard MRI/MRS procedures without drugs or invasive treatments, side effects are minimal but may include discomfort from lying still during the scan or anxiety in enclosed spaces.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prospective and ongoing
This trial's timeline: 3 weeks for screening, Varies for treatment, and prospective and ongoing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The is the quality of the MR spectroscopy which includes spectrum signal-to-noise (SNR) ratio, spectral lineshape, linewidth, and resolution.
Secondary outcome measures
The is the performance improvements of the scanner hardware, software and methodology.

Trial Design

1Treatment groups
Experimental Treatment
Group I: One ArmExperimental Treatment2 Interventions
Subjects receive the same scan

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)Lead Sponsor
2,775 Previous Clinical Trials
2,673,444 Total Patients Enrolled
3 Trials studying Brain Mapping
3,346 Patients Enrolled for Brain Mapping
Steve Li, Ph.D.Principal InvestigatorNational Institute of Mental Health (NIMH)
1 Previous Clinical Trials
200 Total Patients Enrolled
Li An, Ph.D.Principal InvestigatorNational Institute of Mental Health (NIMH)
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

One Arm Clinical Trial Eligibility Overview. Trial Name: NCT01266577 — N/A
Brain Mapping Research Study Groups: One Arm
Brain Mapping Clinical Trial 2023: One Arm Highlights & Side Effects. Trial Name: NCT01266577 — N/A
One Arm 2023 Treatment Timeline for Medical Study. Trial Name: NCT01266577 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to become a participant in this scientific experiment?

"This research seeks 300 individuals of age 18 to 65 with cerebral imaging. In order to be eligible, they must possess a medical record that passes the physical exam and have been previously enrolled in Protocol 01-M-0254 or Protocol 17-M-0181."

Answered by AI

How many participants are included in this clinical experiment?

"Affirmative, the data on clinicaltrials.gov states that patient recruitment is currently in progress for this trial which was first announced on January 27th 2011 and recently updated on October 19th 2022. Two medical centres need to enroll 300 individuals collectively."

Answered by AI

Does the protocol of this clinical trial encompass individuals older than 25?

"Participants in this trial must be of legal age and below the retirement threshold."

Answered by AI

Is this study actively engaging new participants?

"This trial is still recruiting participants, with initial posting on January 27th 2011 and recent updates occurring in October 19th 2022. The details are available for review on clinicaltrials.gov."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
National Institutes of Health Clinical Center
What portion of applicants met pre-screening criteria?
Met criteria
~16 spots leftby Jan 2025